LifeStance Health Finalizes Secondary Offering Terms, Repurchases 7 Million Shares

summarizeSummary

LifeStance Health Group finalized the terms for a secondary offering where institutional investors will sell 25 million shares, while the company will repurchase 7 million shares at $7.01 per share, reducing its total outstanding shares.

check_boxKey Events

• Secondary Offering Finalized

  Institutional investors (TPG and Summit Partners) are selling 25,000,000 shares of common stock at $7.01 per share, generating $175.25 million in proceeds for them. This finalizes the terms of the offering initiated on February 26, 2026.

• Company Share Repurchase

  LifeStance Health Group will repurchase 7,000,000 shares from the underwriter at the offering price of $7.01 per share, totaling $49.07 million. These shares will be retired, reducing the total outstanding share count.

• Net Share Reduction

  The company's repurchase of 7 million shares will result in a net decrease of outstanding shares, despite the larger institutional sale, demonstrating capital management.

• No Proceeds to Company from Secondary Sale

  The company will not receive any proceeds from the sale of shares by the selling stockholders.

auto_awesomeAnalysis

This filing finalizes the pricing and terms of the secondary offering and share repurchase program previously initiated on February 26, 2026. While institutional investors are selling a substantial 25 million shares, the company's commitment to repurchase 7 million shares at $7.01 per share is a significant positive signal. This repurchase, valued at $49.07 million, will reduce the total outstanding shares, demonstrating management's confidence and utilizing a portion of the recently announced $100 million share repurchase program. The offering price is a slight discount to the last reported price but aligns closely with the current market, indicating a reasonable valuation for the transaction.